课题基金 / 基金详情

Myocardial protection for normothermic ischemia and reperfusion in immature heart : effect of mitochondria permeability transition pore inhibitor.

Myocardial protection for normothermic ischemia and reperfusion in immature heart : effect of mitochondria permeability transition pore inhibitor.
未成熟心脏常温缺血和再灌注的心肌保护:线粒体通透性转换孔抑制剂的作用。
批准号:
20591659
负责人:
IMURA Hajime
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2011

项目摘要

项目成果

IMURA Hajime的其他基金

相似基金

相关文献

中文摘要
翻译
异丙酚在缺血再灌注过程中抑制线粒体通透性过渡孔(MPTP),可能具有心肌保护作用,被广泛用作麻醉剂。在本研究中,我们研究了异丙酚是否对未成熟心脏常温缺血再灌注有保护作用。这项研究是在Langendorff模型中使用未成熟的兔子心脏进行的。异丙酚在浓度为1 ~ 4μg/ml时具有保护作用,以2μg/ml时保护效果最好。从心脏功能恢复的角度来看,2μg/ml的保护作用与环孢素(另一种MPTP抑制剂)相当。然而,我们也观察到在4μg/ml或更高浓度时显著的负性肌力效应,在10μg/ml或更高浓度时,这种副作用是至关重要的。
英文摘要
Propofol, which is widely used as an anesthetic agent, inhibits the mitochondria permeability transition pore(MPTP) during reperfusion after ischemia and may work for myocardial protection. In the present study, we investigated whether propofol would protect the immature heart during normothermic ischemia and reperfusion. The study was carried out by using immature rabbit hearts in the Langendorff model. Propofol showed protective effect at concentrations of 1-4μg/ml, and the best protection was at 2μg/ml. The protection at 2μg/ml was equal to that of cyclosporine(another MPTP inhibitor) in a viewpoint of functional recovery of the heart. However, we also observed significant negative inotropic effect at 4μg/ml or higher concentrations and this side effect was crucial at 10μg/ml or higher.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assisting Application for Analytical Transcription of Historical Documents based on Full-text Search System of Document Images.
  • 批准号:
    24700156
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.58万
  • 财政年份:
    2012
  • 负责人:
    IMURA Hajime
  • 依托单位:
海外基金